We are happy to announce that we will be speaking at Connect in Pharma, June 14-15 2023 in Palexpo, Geneva.
For 2023 the conference themes will be addressing trends and challenges from connected health, digital transformation and virtual reality, sustainability, pharma 4.0 and robotics, and so much more.
We would like to invite you to attend our presentation on June 14 at 10am.
Workshop Title: “An exploration of inhalation platforms & the opportunities for new molecules and therapy areas”
Speakers: Bernhard Muellinger and Ross Errington
Recipharm offers a fully integrated service for developing and manufacturing inhalation drug products and devices to the global pharmaceutical market, including pressurised Metered Dose Inhalers (pMDIs), Soft Mist Inhalers (SMIs), Dry Powder Inhalers (DPIs), unit dose and multi dose nasal sprays.
Recipharm has a long history in inhalation device design & development and manufacturing. By developing inhalation products with the device and commercial manufacture in mind we minimise hurdles and reduce time to market.
If you would like to learn more about our inhalation offerings, arrange a meeting with us below.